MDNA - Medicenna Therapeutics Corp - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

with an average price target of $5.41. This is a potential upside of $5.1 (1645.16%) from yesterday's end of day stock price of $0.31.

Medicenna Therapeutics Corp's activity chart (see below) currently has 9 price targets and 10 ratings on display.

Stock Analyst Price Targets - Review

Most recent stock forecast was given by MATTHEW BIEGLER from OPPENHEIMER on 13-Aug-2023. First documented stock forecast 09-Sep-2020.

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy

2 years 2 months 14 days ago
(13-Aug-2023)

0/1 (0%)

$8.2 (215.79%)

Buy

$2.5

$2.19 (706.45%)

$2.5

2 years 4 months ago
(27-Jun-2023)

0/7 (0%)

$2 (400.00%)

Show more analysts

What is MDNA (Medicenna Therapeutics Corp) average time for price targets to be met?

On average it took 0 days on average for the stock forecasts to be realized with a an average price target met ratio 0

Which analyst has the current highest performing score on MDNA (Medicenna Therapeutics Corp) with a proven track record?

SWAYAMPAKULA RAMAKANTH

Which analyst has the current lower performing score on MDNA (Medicenna Therapeutics Corp) with a proven track record?

MATTHEW BIEGLER

Which analyst has the most public recommendations on MDNA (Medicenna Therapeutics Corp)?

Swayampakula Ramakanth works at HC WAINWRIGHT and has 0 price targets and 0 ratings on MDNA

Which analyst is the currently most bullish on MDNA (Medicenna Therapeutics Corp)?

Swayampakula Ramakanth with highest potential upside - $2.19

Which analyst is the currently most reserved on MDNA (Medicenna Therapeutics Corp)?

Matthew Biegler with lowest potential downside - -$0